Kyleena 19.5 mg, Intrauterines Wirkstofffreisetzungssystem

7680661480019 CH-66148 Intrauterines Wirkstofffreisetzungssystem

Associated product:

KYLEENA système intra-utérin SIU 19.5 mg
Kyleena 19.5 mg, Intrauterines Wirkstofffreisetzungssystem
Kyleena 19.5 mg, Intrauterines Wirkstofffreisetzungssystem
Kyleena 19.5 mg, Intrauterines Wirkstofffreisetzungssystem
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Stück
Galenic form
Intrauterines Wirkstofffreisetzungssystem
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/02/2022
Patient information leaflet
Français
18/02/2022
Patient information leaflet
Italien
18/02/2022
Summary of Product Characteristics
Allemand
18/02/2022
Summary of Product Characteristics
Français
18/02/2022
Summary of Product Characteristics
Italien
18/02/2022

Detailed composition

Substance Quantity Type Category
(N/A)
19.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FCOSM
(N/A)
- Substance HNIDK

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
66148
Drug name
Kyleena, Intrauterines Wirkstofffreisetzungssystem
Galenic form
IUWFS
ATC Code
G02BA03
Authorization status
Z
Dispensing category
B
First authorization
16/02/2017
Authorization expiration date
31/12/9999
IT Number
09.02.2.
Domain
Human medicine
Field of application
Intrauterine Kontrazeption

Package details

Description (FR)
KYLEENA système intra-utérin SIU 19.5 mg
Description (DE)
KYLEENA Intrauterinsystem IUP 19.5 mg
Market launch
16/02/2017
Narcotic (BTM)
No